Impossible Objects
Impossible Objects Raises $40M Series B for Industrial 3D Printing
Impossible Objects announced $40M in Series B financing on September 11, 2026. Impossible Objects raised a $40 million Series B led by Inflection Equity to scale its Composite-Based Additive Manufacturing (CBAM) technology and meet growing customer demand.
Round details
The financing includes backing from Inflection Equity, Aaron Wealth Management, OCA Ventures, Impact Capital, Excell Partners. The company did not publish a valuation with the announcement.
- Round: Series B
- Capital announced: $40M
How the company plans to use the capital
Impossible Objects will use the financing to increase production of its industrial additive manufacturing systems, expand customer deployments, and build out the service and commercial organization needed to support a growing installed base.
Why this matters for GTM teams
Impossible Objects says its CBAM technology can produce parts for applications traditionally served by processes such as CNC machining and injection molding, and its announcement cites growing adoption across aerospace, defense and advanced manufacturing.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Impossible Objects Series B announcement.
Company Info
Investors (5)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


